Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 7
2009 12
2010 5
2011 3
2012 4
2013 3
2014 2
2015 2
2016 1
2018 1
2019 5
2020 4
2021 1
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.
Hasan AMM, Cremaschi P, Wetterskog D, Jayaram A, Wong SQ, Williams S, Pasam A, Trigos A, Trujillo B, Grist E, Friedrich S, Vainauskas O, Parry M, Ismail M, Devlies W, Wingate A, Linch M, Naceur-Lombardelli C; PEACE consortium; Swanton C, Jamal-Hanjani M, Lise S, Sandhu S, Attard G. Hasan AMM, et al. Nat Commun. 2023 Aug 10;14(1):4823. doi: 10.1038/s41467-023-40315-9. Nat Commun. 2023. PMID: 37563129 Free PMC article.
Bevacizumab-induced hypertension: pathogenesis and management.
Syrigos KN, Karapanagiotou E, Boura P, Manegold C, Harrington K. Syrigos KN, et al. Among authors: karapanagiotou e. BioDrugs. 2011 Jun 1;25(3):159-69. doi: 10.2165/11590180-000000000-00000. BioDrugs. 2011. PMID: 21627340 Review.
Therapy-induced toxicity of the lungs: an overview.
Charpidou AG, Gkiozos I, Tsimpoukis S, Apostolaki D, Dilana KD, Karapanagiotou EM, Syrigos KN. Charpidou AG, et al. Among authors: karapanagiotou em. Anticancer Res. 2009 Feb;29(2):631-9. Anticancer Res. 2009. PMID: 19331213 Free article. Review.
The role of mTOR in the management of solid tumors: an overview.
Strimpakos AS, Karapanagiotou EM, Saif MW, Syrigos KN. Strimpakos AS, et al. Among authors: karapanagiotou em. Cancer Treat Rev. 2009 Apr;35(2):148-59. doi: 10.1016/j.ctrv.2008.09.006. Epub 2008 Nov 14. Cancer Treat Rev. 2009. PMID: 19013721 Review.
Head and neck cancer in the elderly: an overview on the treatment modalities.
Syrigos KN, Karachalios D, Karapanagiotou EM, Nutting CM, Manolopoulos L, Harrington KJ. Syrigos KN, et al. Among authors: karapanagiotou em. Cancer Treat Rev. 2009 May;35(3):237-45. doi: 10.1016/j.ctrv.2008.11.002. Epub 2008 Dec 18. Cancer Treat Rev. 2009. PMID: 19100689 Review.
Prostate cancer in the elderly.
Syrigos KN, Karapanagiotou E, Harrington KJ. Syrigos KN, et al. Among authors: karapanagiotou e. Anticancer Res. 2005 Nov-Dec;25(6C):4527-33. Anticancer Res. 2005. PMID: 16334137 Free article. Review.
53 results